Whole-Body Photobiomodulation and Chronic Pain Trial

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 12, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2023

Conditions
Chronic Pain
Interventions
DEVICE

Whole-Body Photobiomodulation Therapy

"* All participants entering the trial will receive a course of whole-body PBM therapy~* The NovoTHOR Whole-Body PBM therapy device consists of a hinged, clamshell design with light-emitting diodes (LEDs) arranged to emit near-infrared and visible red light therapy is delivered to the entire body at once.~* Participants will be expected to lie horizontal in the device with the lid as closed as they are comfortable with.~* 18 sessions is the currently recommended and widely instituted and accepted practice with the NovoTHOR device.~* The LED equipment delivers red and near infrared light therapy to the participant~* Session 1 = 6 minutes~* Session 2 = 12 minutes~* Sessions 3-18 = 20 minutes~* Timescale: 3 treatments/week for 6 weeks~* The dosage of LED light (also known as 'fluence') will be equivalent to 25J/cm2. The device will supply a dual wavelength of red and near-infrared light with a 50:50 ratio; 660nm and 850nm respectively"

Trial Locations (1)

Unknown

RECRUITING

Sandwell and West Birmingham NHS Trust, Birmingham

All Listed Sponsors
lead

Sandwell & West Birmingham Hospitals NHS Trust

OTHER